ISG-ARTICLE
Phase 2 Recruiting
100 enrolled
TOMAS2
Phase 2 Completed
130 enrolled
ERASING
Phase 2 Completed
16 enrolled
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue Sarcoma
Phase 2 Completed
17 enrolled
IND200
Phase 2 Completed
24 enrolled
Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma
Phase 2 Completed
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Phase 2 Completed
33 enrolled
ANITA
Phase 2 Terminated
80 enrolled
Flavopiridol in Treating Patients With Recurrent, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
18 enrolled
Image-Guided Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Shoulder, Arm, Hip, or Leg
Phase 2 Completed
98 enrolled 17 charts
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer
Phase 2 Completed
55 enrolled 6 charts
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Phase 2 Terminated
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the Uterus
Phase 2 Completed
20 enrolled 7 charts
S0330 Erlotinib in Treating Patients With Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumor
Phase 2 Completed
24 enrolled 7 charts
SERIO
Phase 2 Completed
38 enrolled
Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of Osteosarcoma
Phase 2 Completed
49 enrolled 21 charts
Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
Phase 2 Completed
10 enrolled 9 charts
Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Phase 2 Terminated
7 enrolled 9 charts
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
Phase 2 Unknown
118 enrolled
Vinorelbine in Treating Children With Recurrent or Refractory Cancers
Phase 2 Completed
50 enrolled
Combination Chemotherapy, Surgery, and Radiation Therapy in Treating Children With Advanced Soft Tissue Sarcoma
Phase 2 Completed
43 enrolled
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Metastatic Rhabdomyosarcoma or Sarcoma
Phase 2 Completed
77 enrolled
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcoma
Phase 2 Completed
Chemotherapy Plus Radiation Therapy Followed by Surgery in Treating Patients With Soft Tissue Sarcoma
Phase 2 Completed
BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors
Phase 2 Completed
76 enrolled
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the Uterus
Phase 2 Terminated
30 enrolled
Combination Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Primary or Recurrent Sarcoma
Phase 2 Withdrawn
Chemotherapy in Treating Patients With Sarcoma of the Uterus
Phase 2 Completed
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Phase 2 Terminated
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
Phase 2 Terminated
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer
Phase 2 Terminated
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the Uterus
Phase 2 Terminated
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Completed
132 enrolled
Chemotherapy in Treating Patients With Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
Phase 2 Terminated
3 enrolled
Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
Phase 2 Completed
48 enrolled
Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
Phase 2 Completed
17 enrolled
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma
Phase 2 Completed
39 enrolled
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
Phase 2 Completed
64 enrolled
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
Phase 2 Completed
60 enrolled
S0423 Pemetrexed Disodium in Treating Patients With Recurrent and Unresectable or Metastatic Chondrosarcoma
Phase 2 Completed
75 enrolled